BC Cancer - Vancouver Centre
BC Cancer - Vancouver Centre
Vancouver, British Columbia, Canada4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) | Neoplasms by Histologic Type, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, breast carcinoma in situ, carcinoma, ductal breast carcinoma in situ, epithelial neoplasm, in situ carcinoma, neoplasm | Active, not recruiting | Not stated | 2026-10-05 | NCT04797299 | |
| Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-cell non-Hodgkin lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-07-20 | NCT04703192 | |
| Hypofractionated LocoRegional Radiotherapy in Breast Cancer | Hemic and Lymphatic Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, lymphatic system disorder, lymphedema, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-06-17 | NCT04228991 | |
| PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Active, not recruiting | Phase 2 | 2025-08-20 | NCT04015622 |